水痘弱毒生ワクチンの世界市場2016

◆英語タイトル:Global Varicella Attenuated Live Vaccine Market Research Report 2016
◆商品コード:QYR60918039
◆発行会社(調査会社):QYResearch
◆発行日:2016年9月6日
◆ページ数:100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single UserUSD2,900 ⇒換算¥327,700見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD5,800 ⇒換算¥655,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規販売代理店です。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
※当調査レポートでは、水痘弱毒生ワクチンの世界市場について調査・分析し、市場概観、市場動向、水痘弱毒生ワクチンの世界市場規模、市場予測、地域別市場規模(日本市場、中国市場、米国市場、欧州市場など)、製造コスト分析、主要なメーカー分析(企業概要、主な製品概要、生産・販売動向、連絡先など)、価格情報、市場環境分析、輸出・輸入データ、市場シェア分析などを含め、以下の構成でお届けいたします。

・水痘弱毒生ワクチンの世界市場:市場概要
・水痘弱毒生ワクチンの世界市場:市場動向
・水痘弱毒生ワクチンの世界市場:市場規模、市場規模予測
・水痘弱毒生ワクチンの地域別市場規模(日本市場、中国市場、アメリカ市場、ヨーロッパ市場など)
・水痘弱毒生ワクチンの製造コスト分析
・水痘弱毒生ワクチンの主要なメーカー分析(企業情報、主な製品概要、生産・販売動向、連絡先など)
・水痘弱毒生ワクチンの価格動向
・水痘弱毒生ワクチンの世界市場:市場環境分析
・水痘弱毒生ワクチンの世界市場:輸出・輸入データ
・水痘弱毒生ワクチンの世界市場:市場シェア分析
・水痘弱毒生ワクチンの世界市場:結論
...
【レポートの概要】

Notes:Production, means the output of Varicella Attenuated Live Vaccine
Revenue, means the sales value of Varicella Attenuated Live Vaccine

This report studies Varicella Attenuated Live Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
GSK
Merck
Beijing Tiantan Biological Products
Chengdu Institute of Biological Products
Shanghai Institute of Biological Products
Changchun Keygen Biological Products
Changsheng

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Varicella Attenuated Live Vaccine in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on consumption, market share and growth rate of Varicella Attenuated Live Vaccine in each application, can be divided into
Application 1
Application 2
Application 3

【レポートの目次】

Table of Contents

Global Varicella Attenuated Live Vaccine Market Research Report 2016
1 Varicella Attenuated Live Vaccine Market Overview
1.1 Product Overview and Scope of Varicella Attenuated Live Vaccine
1.2 Varicella Attenuated Live Vaccine Segment by Type
1.2.1 Global Production Market Share of Varicella Attenuated Live Vaccine by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Varicella Attenuated Live Vaccine Segment by Application
1.3.1 Varicella Attenuated Live Vaccine Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Varicella Attenuated Live Vaccine Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Varicella Attenuated Live Vaccine (2011-2021)

2 Global Varicella Attenuated Live Vaccine Market Competition by Manufacturers
2.1 Global Varicella Attenuated Live Vaccine Production and Share by Manufacturers (2015 and 2016)
2.2 Global Varicella Attenuated Live Vaccine Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Varicella Attenuated Live Vaccine Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Varicella Attenuated Live Vaccine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Varicella Attenuated Live Vaccine Market Competitive Situation and Trends
2.5.1 Varicella Attenuated Live Vaccine Market Concentration Rate
2.5.2 Varicella Attenuated Live Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Varicella Attenuated Live Vaccine Production, Revenue (Value) by Region (2011-2016)
3.1 Global Varicella Attenuated Live Vaccine Production and Market Share by Region (2011-2016)
3.2 Global Varicella Attenuated Live Vaccine Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Varicella Attenuated Live Vaccine Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Varicella Attenuated Live Vaccine Consumption by Regions (2011-2016)
4.2 North America Varicella Attenuated Live Vaccine Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Varicella Attenuated Live Vaccine Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Varicella Attenuated Live Vaccine Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Varicella Attenuated Live Vaccine Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Varicella Attenuated Live Vaccine Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Varicella Attenuated Live Vaccine Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Varicella Attenuated Live Vaccine Production, Revenue (Value), Price Trend by Type
5.1 Global Varicella Attenuated Live Vaccine Production and Market Share by Type (2011-2016)
5.2 Global Varicella Attenuated Live Vaccine Revenue and Market Share by Type (2011-2016)
5.3 Global Varicella Attenuated Live Vaccine Price by Type (2011-2016)
5.4 Global Varicella Attenuated Live Vaccine Production Growth by Type (2011-2016)

6 Global Varicella Attenuated Live Vaccine Market Analysis by Application
6.1 Global Varicella Attenuated Live Vaccine Consumption and Market Share by Application (2011-2016)
6.2 Global Varicella Attenuated Live Vaccine Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Varicella Attenuated Live Vaccine Manufacturers Profiles/Analysis
7.1 GSK
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 GSK Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Merck
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Merck Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Beijing Tiantan Biological Products
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Beijing Tiantan Biological Products Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Chengdu Institute of Biological Products
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Chengdu Institute of Biological Products Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Shanghai Institute of Biological Products
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Shanghai Institute of Biological Products Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Changchun Keygen Biological Products
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Changchun Keygen Biological Products Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Changsheng
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Varicella Attenuated Live Vaccine Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Changsheng Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview

8 Varicella Attenuated Live Vaccine Manufacturing Cost Analysis
8.1 Varicella Attenuated Live Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Varicella Attenuated Live Vaccine

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Varicella Attenuated Live Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Varicella Attenuated Live Vaccine Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Varicella Attenuated Live Vaccine Market Forecast (2016-2021)
12.1 Global Varicella Attenuated Live Vaccine Production, Revenue Forecast (2016-2021)
12.2 Global Varicella Attenuated Live Vaccine Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Varicella Attenuated Live Vaccine Production Forecast by Type (2016-2021)
12.4 Global Varicella Attenuated Live Vaccine Consumption Forecast by Application (2016-2021)
12.5 Varicella Attenuated Live Vaccine Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List of Tables and Figures

Figure Picture of Varicella Attenuated Live Vaccine
Figure Global Production Market Share of Varicella Attenuated Live Vaccine by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Varicella Attenuated Live Vaccine Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Varicella Attenuated Live Vaccine Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Varicella Attenuated Live Vaccine Production of Key Manufacturers (2015 and 2016)
Table Global Varicella Attenuated Live Vaccine Production Share by Manufacturers (2015 and 2016)
Figure 2015 Varicella Attenuated Live Vaccine Production Share by Manufacturers
Figure 2016 Varicella Attenuated Live Vaccine Production Share by Manufacturers
Table Global Varicella Attenuated Live Vaccine Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Varicella Attenuated Live Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Varicella Attenuated Live Vaccine Revenue Share by Manufacturers
Table 2016 Global Varicella Attenuated Live Vaccine Revenue Share by Manufacturers
Table Global Market Varicella Attenuated Live Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Varicella Attenuated Live Vaccine Average Price of Key Manufacturers in 2015
Table Manufacturers Varicella Attenuated Live Vaccine Manufacturing Base Distribution and Sales Area
Table Manufacturers Varicella Attenuated Live Vaccine Product Type
Figure Varicella Attenuated Live Vaccine Market Share of Top 3 Manufacturers
Figure Varicella Attenuated Live Vaccine Market Share of Top 5 Manufacturers
Table Global Varicella Attenuated Live Vaccine Production by Regions (2011-2016)
Figure Global Varicella Attenuated Live Vaccine Production and Market Share by Regions (2011-2016)
Figure Global Varicella Attenuated Live Vaccine Production Market Share by Regions (2011-2016)
Figure 2015 Global Varicella Attenuated Live Vaccine Production Market Share by Regions
Table Global Varicella Attenuated Live Vaccine Revenue by Regions (2011-2016)
Table Global Varicella Attenuated Live Vaccine Revenue Market Share by Regions (2011-2016)
Table 2015 Global Varicella Attenuated Live Vaccine Revenue Market Share by Regions
Table Global Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table China Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table India Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Varicella Attenuated Live Vaccine Consumption Market by Regions (2011-2016)
Table Global Varicella Attenuated Live Vaccine Consumption Market Share by Regions (2011-2016)
Figure Global Varicella Attenuated Live Vaccine Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Varicella Attenuated Live Vaccine Consumption Market Share by Regions
Table North America Varicella Attenuated Live Vaccine Production, Consumption, Import & Export (2011-2016)
Table Europe Varicella Attenuated Live Vaccine Production, Consumption, Import & Export (2011-2016)
Table China Varicella Attenuated Live Vaccine Production, Consumption, Import & Export (2011-2016)
Table Japan Varicella Attenuated Live Vaccine Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Varicella Attenuated Live Vaccine Production, Consumption, Import & Export (2011-2016)
Table India Varicella Attenuated Live Vaccine Production, Consumption, Import & Export (2011-2016)
Table Global Varicella Attenuated Live Vaccine Production by Type (2011-2016)
Table Global Varicella Attenuated Live Vaccine Production Share by Type (2011-2016)
Figure Production Market Share of Varicella Attenuated Live Vaccine by Type (2011-2016)
Figure 2015 Production Market Share of Varicella Attenuated Live Vaccine by Type
Table Global Varicella Attenuated Live Vaccine Revenue by Type (2011-2016)
Table Global Varicella Attenuated Live Vaccine Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Varicella Attenuated Live Vaccine by Type (2011-2016)
Figure 2015 Revenue Market Share of Varicella Attenuated Live Vaccine by Type
Table Global Varicella Attenuated Live Vaccine Price by Type (2011-2016)
Figure Global Varicella Attenuated Live Vaccine Production Growth by Type (2011-2016)
Table Global Varicella Attenuated Live Vaccine Consumption by Application (2011-2016)
Table Global Varicella Attenuated Live Vaccine Consumption Market Share by Application (2011-2016)
Figure Global Varicella Attenuated Live Vaccine Consumption Market Share by Application in 2015
Table Global Varicella Attenuated Live Vaccine Consumption Growth Rate by Application (2011-2016)
Figure Global Varicella Attenuated Live Vaccine Consumption Growth Rate by Application (2011-2016)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Varicella Attenuated Live Vaccine Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Varicella Attenuated Live Vaccine Market Share (2011-2016)
Table Beijing Tiantan Biological Products Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Beijing Tiantan Biological Products Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Beijing Tiantan Biological Products Varicella Attenuated Live Vaccine Market Share (2011-2016)
Table Chengdu Institute of Biological Products Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chengdu Institute of Biological Products Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Chengdu Institute of Biological Products Varicella Attenuated Live Vaccine Market Share (2011-2016)
Table Shanghai Institute of Biological Products Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai Institute of Biological Products Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Shanghai Institute of Biological Products Varicella Attenuated Live Vaccine Market Share (2011-2016)
Table Changchun Keygen Biological Products Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Changchun Keygen Biological Products Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Changchun Keygen Biological Products Varicella Attenuated Live Vaccine Market Share (2011-2016)
Table Changsheng Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Changsheng Varicella Attenuated Live Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Changsheng Varicella Attenuated Live Vaccine Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Varicella Attenuated Live Vaccine
Figure Manufacturing Process Analysis of Varicella Attenuated Live Vaccine
Figure Varicella Attenuated Live Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Varicella Attenuated Live Vaccine Major Manufacturers in 2015
Table Major Buyers of Varicella Attenuated Live Vaccine
Table Distributors/Traders List
Figure Global Varicella Attenuated Live Vaccine Production and Growth Rate Forecast (2016-2021)
Figure Global Varicella Attenuated Live Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table Global Varicella Attenuated Live Vaccine Production Forecast by Regions (2016-2021)
Table Global Varicella Attenuated Live Vaccine Consumption Forecast by Regions (2016-2021)
Table Global Varicella Attenuated Live Vaccine Production Forecast by Type (2016-2021)
Table Global Varicella Attenuated Live Vaccine Consumption Forecast by Application (2016-2021)


★調査レポート[水痘弱毒生ワクチンの世界市場2016] (コード:QYR60918039)販売に関する免責事項を必ずご確認ください。
★調査レポート[水痘弱毒生ワクチンの世界市場2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆